8-K
filed March 15, 2024, 7:59 PM ET
ticker QTTB
CIK 0001661998
M&A
confidence high
sentiment neutral
materiality 0.70
Homology stockholders approve all merger-related proposals with Q32 Bio
Q32 Bio Inc.
- Stock Issuance Proposal passed: 35M for, 4.2M against, 9.3M broker non-votes.
- Authorized shares increased to 400M, and reverse stock split (1:10 to 1:30) approved.
- 2024 Stock Option Plan and ESPP approved; Merger compensation advisory also passed.
- Adjournment proposal approved but not needed as all key proposals passed.
- Special Meeting had 48.6M shares present (83.6% of outstanding).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Advisory, non-binding approval of certain compensation arrangements for named executive officers in connection with the Merger at the 2024-03-15 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 33,917,653 4,789,759 622,700 9,271,737
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Amendment to the Restated Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1-for-10 to 1-for-30 at the 2024-03-15 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 43,418,119 5,081,292 102,438 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Amendment to the Restated Certificate of Incorporation to increase the number of authorized shares of common stock to 400,000,000 at the 2024-03-15 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 42,910,808 5,634,844 56,197 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved 2024 Employee Stock Purchase Plan at the 2024-03-15 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 28,097,015 11,039,000 194,097 9,271,737
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Adjournment of the Special Meeting, if necessary, to solicit additional proxies at the 2024-03-15 meeting.
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 42,818,421 3,172,749 2,610,679 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved 2024 Stock Option and Incentive Plan at the 2024-03-15 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 25,536,544 13,627,863 165,705 9,271,737
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Q32 Bio Inc. shareholders approved Issuance of shares of common stock of Homology to stockholders of Q32 Bio Inc. pursuant to the terms of the Agreement and Plan of Merger at the 2024-03-15 meeting.
- Proposal
- merger approval
- Outcome
- passed
- Meeting
- 2024-03-15
Exact text from the filing
Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 35,052,562 4,241,901 35,649 9,271,737
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.